Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 10:06:29 UTC |
---|
Update Date | 2021-09-26 23:04:43 UTC |
---|
HMDB ID | HMDB0252254 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Fidexaban |
---|
Description | 2-{[2-(5-carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-[3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridin-4-yl](methyl)amino}acetic acid belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. 2-{[2-(5-carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-[3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridin-4-yl](methyl)amino}acetic acid is a very strong basic compound (based on its pKa). This compound has been identified in human blood as reported by (PMID: 31557052 ). Fidexaban is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Fidexaban is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CN(CC(O)=O)C1=C(F)C(OC2=CC=CC(=C2)C2=NCCN2C)=NC(OC2=C(O)C=CC(=C2)C(N)=N)=C1F InChI=1S/C25H24F2N6O5/c1-32-9-8-30-23(32)14-4-3-5-15(10-14)37-24-19(26)21(33(2)12-18(35)36)20(27)25(31-24)38-17-11-13(22(28)29)6-7-16(17)34/h3-7,10-11,34H,8-9,12H2,1-2H3,(H3,28,29)(H,35,36) |
---|
Synonyms | Value | Source |
---|
2-{[2-(5-carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-[3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridin-4-yl](methyl)amino}acetate | Generator | N-(2-(5-(Amino(imino)methyl)-2-hydroxyphenoxy)-3,5-difluoro-6-(3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy)pyridin-4-yl)-N-methylglycine | MeSH |
|
---|
Chemical Formula | C25H24F2N6O5 |
---|
Average Molecular Weight | 526.4921 |
---|
Monoisotopic Molecular Weight | 526.177624318 |
---|
IUPAC Name | 2-{[2-(5-carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-[3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridin-4-yl](methyl)amino}acetic acid |
---|
Traditional Name | fidexaban |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN(CC(O)=O)C1=C(F)C(OC2=CC=CC(=C2)C2=NCCN2C)=NC(OC2=C(O)C=CC(=C2)C(N)=N)=C1F |
---|
InChI Identifier | InChI=1S/C25H24F2N6O5/c1-32-9-8-30-23(32)14-4-3-5-15(10-14)37-24-19(26)21(33(2)12-18(35)36)20(27)25(31-24)38-17-11-13(22(28)29)6-7-16(17)34/h3-7,10-11,34H,8-9,12H2,1-2H3,(H3,28,29)(H,35,36) |
---|
InChI Key | NPNSVNGQJGRSNR-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Ethers |
---|
Direct Parent | Diarylethers |
---|
Alternative Parents | |
---|
Substituents | - Diaryl ether
- Alpha-amino acid
- Alpha-amino acid or derivatives
- Phenoxy compound
- Imidazolyl carboxylic acid derivative
- Phenol ether
- Polyhalopyridine
- Dialkylarylamine
- Tertiary aliphatic/aromatic amine
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Aminopyridine
- Pyridine
- Aryl fluoride
- Imidolactam
- Benzenoid
- Monocyclic benzene moiety
- Aryl halide
- Heteroaromatic compound
- 2-imidazoline
- Tertiary amine
- Amino acid or derivatives
- Amino acid
- Amidine
- Azacycle
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboxylic acid amidine
- Carboxylic acid derivative
- Carboxylic acid
- Carboximidamide
- Monocarboxylic acid or derivatives
- Carbonyl group
- Organic oxide
- Organic nitrogen compound
- Amine
- Organonitrogen compound
- Organofluoride
- Hydrocarbon derivative
- Organohalogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 208.578 | 30932474 | DeepCCS | [M-H]- | 206.183 | 30932474 | DeepCCS | [M-2H]- | 239.067 | 30932474 | DeepCCS | [M+Na]+ | 214.491 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Fidexaban,3TMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 4476.0 | Semi standard non polar | 33892256 | Fidexaban,3TMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 3655.1 | Standard non polar | 33892256 | Fidexaban,3TMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 5813.2 | Standard polar | 33892256 | Fidexaban,3TMS,isomer #2 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(N)=N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 4307.2 | Semi standard non polar | 33892256 | Fidexaban,3TMS,isomer #2 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(N)=N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 3610.6 | Standard non polar | 33892256 | Fidexaban,3TMS,isomer #2 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(N)=N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 6318.9 | Standard polar | 33892256 | Fidexaban,3TMS,isomer #3 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 4381.0 | Semi standard non polar | 33892256 | Fidexaban,3TMS,isomer #3 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 3865.3 | Standard non polar | 33892256 | Fidexaban,3TMS,isomer #3 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 5907.2 | Standard polar | 33892256 | Fidexaban,3TMS,isomer #4 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 4463.7 | Semi standard non polar | 33892256 | Fidexaban,3TMS,isomer #4 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 3791.9 | Standard non polar | 33892256 | Fidexaban,3TMS,isomer #4 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 6030.5 | Standard polar | 33892256 | Fidexaban,3TMS,isomer #5 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 4421.6 | Semi standard non polar | 33892256 | Fidexaban,3TMS,isomer #5 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 3745.7 | Standard non polar | 33892256 | Fidexaban,3TMS,isomer #5 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 5899.2 | Standard polar | 33892256 | Fidexaban,3TMS,isomer #6 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 4480.6 | Semi standard non polar | 33892256 | Fidexaban,3TMS,isomer #6 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 3686.2 | Standard non polar | 33892256 | Fidexaban,3TMS,isomer #6 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 6007.7 | Standard polar | 33892256 | Fidexaban,3TMS,isomer #7 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 4417.0 | Semi standard non polar | 33892256 | Fidexaban,3TMS,isomer #7 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 3869.5 | Standard non polar | 33892256 | Fidexaban,3TMS,isomer #7 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 5916.0 | Standard polar | 33892256 | Fidexaban,4TMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 4347.8 | Semi standard non polar | 33892256 | Fidexaban,4TMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 3755.5 | Standard non polar | 33892256 | Fidexaban,4TMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 5550.0 | Standard polar | 33892256 | Fidexaban,4TMS,isomer #2 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 4432.4 | Semi standard non polar | 33892256 | Fidexaban,4TMS,isomer #2 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 3690.3 | Standard non polar | 33892256 | Fidexaban,4TMS,isomer #2 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 5634.5 | Standard polar | 33892256 | Fidexaban,4TMS,isomer #3 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 4353.5 | Semi standard non polar | 33892256 | Fidexaban,4TMS,isomer #3 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 3882.0 | Standard non polar | 33892256 | Fidexaban,4TMS,isomer #3 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 5539.2 | Standard polar | 33892256 | Fidexaban,4TMS,isomer #4 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 4402.6 | Semi standard non polar | 33892256 | Fidexaban,4TMS,isomer #4 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 3765.2 | Standard non polar | 33892256 | Fidexaban,4TMS,isomer #4 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 5547.2 | Standard polar | 33892256 | Fidexaban,5TMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 4365.5 | Semi standard non polar | 33892256 | Fidexaban,5TMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 3771.1 | Standard non polar | 33892256 | Fidexaban,5TMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)=CC=C3O[Si](C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C)=C2F)=C1 | 5212.2 | Standard polar | 33892256 | Fidexaban,3TBDMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 4908.9 | Semi standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 4264.1 | Standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #1 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 5765.7 | Standard polar | 33892256 | Fidexaban,3TBDMS,isomer #2 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(N)=N[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 4822.7 | Semi standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #2 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(N)=N[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 4191.0 | Standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #2 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(N)=N[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 6263.1 | Standard polar | 33892256 | Fidexaban,3TBDMS,isomer #3 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 4816.7 | Semi standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #3 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 4480.3 | Standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #3 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 5825.5 | Standard polar | 33892256 | Fidexaban,3TBDMS,isomer #4 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 4905.2 | Semi standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #4 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 4401.1 | Standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #4 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O[Si](C)(C)C(C)(C)C)=C2F)=C1 | 5860.2 | Standard polar | 33892256 | Fidexaban,3TBDMS,isomer #5 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 4849.2 | Semi standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #5 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 4336.8 | Standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #5 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 5845.9 | Standard polar | 33892256 | Fidexaban,3TBDMS,isomer #6 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 4928.4 | Semi standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #6 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 4284.0 | Standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #6 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C3O[Si](C)(C)C(C)(C)C)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 5867.7 | Standard polar | 33892256 | Fidexaban,3TBDMS,isomer #7 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 4866.7 | Semi standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #7 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 4482.6 | Standard non polar | 33892256 | Fidexaban,3TBDMS,isomer #7 | CN1CCN=C1C1=CC=CC(OC2=NC(OC3=CC(C(=N[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C3O)=C(F)C(N(C)CC(=O)O)=C2F)=C1 | 5805.2 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_2_5) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_2_6) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fidexaban GC-MS (TBDMS_2_7) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fidexaban 10V, Positive-QTOF | splash10-03di-0000090000-7c72d95f461bb16ba1c9 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fidexaban 20V, Positive-QTOF | splash10-03fr-0000790000-d8e3a4a26d8c5db76d39 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fidexaban 40V, Positive-QTOF | splash10-001r-2100920000-89ebbefea1b91564561c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fidexaban 10V, Negative-QTOF | splash10-004i-0000090000-0810d1406e152a155d05 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fidexaban 20V, Negative-QTOF | splash10-0ar0-4000950000-211386a492c1267f2cb7 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fidexaban 40V, Negative-QTOF | splash10-0006-9300810000-fb4760dffe248646d2d2 | 2021-10-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 4322 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|